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Introduction
Gretchen Birbeck is a Professor of Neurology and Epide-
miology at Michigan State University. She has roles in
clinical neurology, epidemiology and health services
research with a keen interest in the optimal management
of neurological conditions in resource-limited settings.
Based in southern Africa for half of the year, she has first-
hand experience in the management of such conditions
and, in particular, of epilepsy, which is one of her main
areas of interest (Figure 1).
Gretchen is also one of the guest editors for the BMC
Medicine article collection, Medicine for Global Health.
Here we talk to Gretchen about her personal views on
the challenges of epilepsy management from a global
perspective.
The podcast for this interview is available at: http://www.
biomedcentral.com/sites/2999/download/Birbeck.mp3
1) How is epilepsy currently managed in resource-limited
settings, and what are the difficulties with its current
management in these settings?
There isn’t really one answer to that as care in different
resource-limited settings is very dependent upon care-
seeking behaviors, the expertise of existing healthcare
personnel (especially at the primary healthcare level) and
drug availability. Where there are active community-
based efforts to bring epilepsy and people with epilepsy
“out of the shadows”, care-seeking will be primarily lim-
ited by patient resources and transport infrastructure.
But if people with epilepsy and their families misunder-
stand the nature of seizures, epilepsy may never be
brought to the formal healthcare sector for assessment;
people will see traditional healers. Primary healthcare
workers need to have adequate training in the basics of
diagnosis and treatment with recourse to referral for
higher level evaluation in complicated cases. Without
trained primary healthcare staff, most patients will not
get treated at all. The development of training programs
appropriate for a specific resource-limited setting really
needs to be guided by physician-level experts who know
the healthcare environment, and they also need to know
the local culture and the local epidemiology of disease.
And even if all of these are in place, if antiepileptic drug
supply lines are inefficient or inconsistent, adequate man-
agement isn’t possible. It is a chain of “necessary but not
sufficient” factors and each of these likely vary from
country-to-country and possibly even within country in
resource-limited settings.
2) What are the main differences with epilepsy
management in resource-limited settings as compared to
high income countries?
Many of the things people with epilepsy struggle with are
universal. Women with epilepsy worry about the impact
of their condition and their medications on their offspring.
Children with epilepsy struggle to be accepted and succeed
in school. Adolescents with epilepsy fear rejection from
their peers. These are pretty common issues. Medication
side effects are problematic whether you have two drugs
to choose from or ten. Comorbid and often untreated
depression and anxiety degrade quality of life for people
with epilepsy wherever you are. Access to medications is
more problematic in resource-limited settings - but if
you’ve worked with the employed but uninsured in the
US, you know this is NOT a problem unique to “resource-
limited settings”.
What is different are the consequences of the medical,
social and economic burden of epilepsy in settings
where people are already on the cusp of survival. If you
cook over an open flame, have poor seizure control
because medication access is intermittent and live where
contagion fears are common, a generalized seizure can
mean extensive burns and death or a lifetime physical
disability. For women with epilepsy, spousal or familial
abandonment due to misconceptions regarding epilepsy
and in the absence of a social safety net results in vul-
nerability to sexual predators and marginal survival
Correspondence: birbeck@msu.edu
International Neurologic & Psychiatric Epidemiology Program, Michigan State
University, 909 Fee Road, #324 West Fee Hall, East Lansing, MI 48824, USA
Birbeck BMC Medicine 2013, 11:70
http://www.biomedcentral.com/1741-7015/11/70
© 2013 Birbeck; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
at best. If educational opportunities are lost due to epi-
lepsy, those with childhood onset face lifetime limita-
tions in their personal capacity even if their epilepsy
remits by adulthood.
3) Have there been any implications for neurology in
resource-limited settings in terms of results from the
Global Burden of Disease (GBD) study?
The most impressive outcome for the epilepsy field in the
Global Burden 2010 work was the value assigned to having
epilepsy in the Disability-Adjusted Life Year (DALY). Pre-
vious DALY assignments were made largely by expert
groups and their opinions. In the GBD2010 survey of
almost 14,000 people from a range of global settings (the
US, Bangladesh, Indonesia, Peru and Tanzania), severe
epilepsy was rated as having a DALY of 0.657. This was
almost the highest rated disability assessed - even
untreated AIDS without antiretroviral medications had a
less burdensome DALY at 0.547, remembering that a
DALY of 1 essentially means ‘dead’.
4) Where do you think work should be done in this area
to improve clinical outcome of those affected?
Geographically “where"? There is doubtless room for
improvement everywhere. Even in economically developed
settings there are substantial healthcare disparities being
discovered among people with epilepsy.
In resource-limited settings, I think we need to have a
dual research agenda - one aimed at improving the lives of
people with epilepsy through improved healthcare services
and community-oriented efforts to diminish the social and
economic impact of the condition. The second area for
work should be on the prevention of epilepsy. There are
ample data pointing at some of the more common causes
of epilepsy in these environments and many of the causes
are potentially modifiable, for example, better manage-
ment of acute cerebral malaria, and better management of
antenatal risk factors for perinatal brain injury.
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